KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Treasury Shares (2019 - 2025)

BioNTech SE's Treasury Shares history spans 7 years, with the latest figure at -$9.0 million for Q4 2025.

  • On a quarterly basis, Treasury Shares rose 2.47% to -$9.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$9.0 million, a 2.47% increase, with the full-year FY2025 number at -$8.7 million, up 5.34% from a year prior.
  • Treasury Shares hit -$9.0 million in Q4 2025 for BioNTech SE, up from -$9.5 million in the prior quarter.
  • Over the last five years, Treasury Shares for BNTX hit a ceiling of -$4.3 million in Q1 2022 and a floor of -$11.8 million in Q3 2023.
  • Historically, Treasury Shares has averaged -$8.7 million across 5 years, with a median of -$9.2 million in 2024.
  • Biggest five-year swings in Treasury Shares: crashed 175.96% in 2021 and later rose 26.48% in 2025.
  • Tracing BNTX's Treasury Shares over 5 years: stood at -$4.3 million in 2021, then decreased by 24.39% to -$5.4 million in 2022, then plummeted by 114.9% to -$11.6 million in 2023, then grew by 20.91% to -$9.2 million in 2024, then increased by 2.47% to -$9.0 million in 2025.
  • Business Quant data shows Treasury Shares for BNTX at -$9.0 million in Q4 2025, -$9.5 million in Q3 2025, and -$9.3 million in Q2 2025.